Pearl, based in California, confirmed plans to introduce its Practice Intelligence AI solution in Europe, according to a press release.
“Practice Intelligence® delivers unrivaled insights into population-wide patient health and treatment trends, accuracy of clinical findings and optimized workflows,” chief clinical officer at Pearl, Dr. Kyle Stanley, said. “Expanding support for Practice Intelligence® to Europe will give European dentists the benefits of the most complete clinical AI toolset in dentistry and is a testament to Pearl’s commitment to accelerating the global adoption of AI-backed dental care.”
The dental AI solutions provider confirmed plans to expand its technology at the 2023 International Dental Show in Cologne, Germany, where the company showcased its FDA-approved AI technology. For the launch, the company counts with the support of various software integration and distribution partners, including Planmeca and 3M.
“Designed to optimize dental practice operations, elevate clinical performance and grow production, Practice Intelligence® synthesizes actionable insights from AI-powered evaluation of X-rays and analysis of treatment data across a practice’s entire patient population,” a recent press release states.
The expansion follows the company’s Second Opinion® clinical radiology solution launch at the 2021 International Dental Show.
The AI-powered real-time pathology detection dental aid has been granted regulatory clearances for clinical deployment in the United States, Canada, Australia, New Zealand, United Arab Emirates, Saudi Arabia, Brazil and Israel.
“Pearl’s expansion in Europe will ensure that the rate of AI adoption among dentists around the world continues to climb,” CEO and Founder of Pearl, Ophir Tanz, said. “In bringing the full breadth of AI’s capabilities and benefits to more dental practices around the world, we proudly continue to serve our mission of revolutionizing the standard of dental care on a global scale.”